Nipro Corp
TSE:8086

Watchlist Manager
Nipro Corp Logo
Nipro Corp
TSE:8086
Watchlist
Price: 1 452 JPY 1.01% Market Closed
Market Cap: 236.8B JPY

Nipro Corp
Cost of Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nipro Corp
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Nipro Corp
TSE:8086
Cost of Revenue
-ÂĄ456.3B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Hoya Corp
TSE:7741
Cost of Revenue
-ÂĄ118B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-2%
H
Hogy Medical Co Ltd
TSE:3593
Cost of Revenue
-ÂĄ25.9B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Eiken Chemical Co Ltd
TSE:4549
Cost of Revenue
-ÂĄ24.6B
CAGR 3-Years
-3%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Menicon Co Ltd
TSE:7780
Cost of Revenue
-ÂĄ56.8B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Mani Inc
TSE:7730
Cost of Revenue
-ÂĄ10.7B
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-7%
No Stocks Found

Nipro Corp
Glance View

Market Cap
236.8B JPY
Industry
Health Care

Nipro Corporation, a prominent player in the medical industry, began as a humble glass-tubing business in the heart of Japan in 1954. Over the decades, it metamorphosed into a sprawling conglomerate with a nuanced focus on healthcare. Today, Nipro is intricately woven into the fabric of the medical supply chain. Its products range from dialysis equipment to diabetes care and even medical glass products, evidencing a broad spectrum of specialties. This diversification is not simply an expansion but a strategic integration that enables the company to leverage its expertise across related domains, ensuring resilience in the ever-evolving healthcare market. The engine powering Nipro’s business model lies in its vertical integration and global footprint. By manufacturing an array of products internally, from raw materials like glass and plastics to final medical devices, Nipro maintains stringent quality control and cost efficiencies. Beyond Japan, the company has established a significant presence in over 50 countries, tapping into diverse markets with its extensive portfolio. Strategic partnerships and mergers further bolster its global expansiveness, enhancing its distribution networks. The seamless intersection of innovation, quality, and market reach solidifies Nipro's stature as a leading entity in healthcare solutions, driving its sustained financial performance.

Intrinsic Value
2 306.55 JPY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Nipro Corp's Cost of Revenue?
Cost of Revenue
-456.3B JPY

Based on the financial report for Jun 30, 2025, Nipro Corp's Cost of Revenue amounts to -456.3B JPY.

What is Nipro Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-7%

Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Nipro Corp have been -9% over the past three years , -8% over the past five years , and -7% over the past ten years .

Back to Top